• Actinomyces, Molecular Method
  • Oncuria®, Multiplex Biomarker Immunoassay for Bladder Cancer, Urine
  • Occult Blood, Fecal
  • The Enhanced Liver Fibrosis (ELF)
  • Inherited Insulin Resistance Syndromes (INSR) Genetic Testing
  • Carcinoembryonic Antigen (CEA), Peritoneal Fluid
  • PCA3/KLK3 (prostate cancer antigen 3/kallikrein-related peptidase 3) ratio
  • Thyroglobulin Panel
  • Phospholipid (Cardiolipin) Antibody, IgM
  • Growth Hormone Releasing Hormone
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Cancer Antigen (CA) 19-9, Pleural Fluid
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Cancer Antigen (CA) 19-9, Pleural Fluid
Medical Test

References
Access to Cancer Antigen (CA) 19-9, Pleural Fluid is restricted.